Texas Top Legal Officer Sues Tylenol Manufacturers Over Autism Allegations

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of acetaminophen, alleging the corporations hid alleged dangers that the medication posed to children's cognitive development.

The court filing comes four weeks after Former President Trump promoted an unsubstantiated connection between using Tylenol - referred to as acetaminophen - during pregnancy and autism in young ones.

Paxton is suing the pharmaceutical giant, which once produced the drug, the only pain reliever approved for expectant mothers, and the current manufacturer, which presently makes it.

In a declaration, he stated they "betrayed America by making money from pain and promoting medication ignoring the dangers."

The manufacturer says there is no credible evidence tying Tylenol to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering millions to line their pockets," the attorney general, from the Republican party, declared.

Kenvue stated officially that it was "seriously troubled by the dissemination of inaccurate information on the safety of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its official site, the company also mentioned it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a established connection between taking paracetamol and autism spectrum disorder."

Organizations speaking for medical professionals and medical practitioners concur.

The leading OB-GYN organization has stated acetaminophen - the primary component in acetaminophen - is a restricted selection for women during pregnancy to treat pain and elevated temperature, which can present serious health risks if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the use of acetaminophen in any stage of gestation causes neurological conditions in young ones," the group said.

This legal action references latest statements from the former administration in arguing the medication is potentially dangerous.

In recent weeks, the former president caused concern from health experts when he instructed women during pregnancy to "struggle intensely" not to take Tylenol when ill.

Federal regulators then released a statement that physicians should consider limiting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Robert F Kennedy Jr, who manages the FDA, had promised in April to conduct "comprehensive study program" that would determine the cause of autism spectrum disorder in a limited time.

But authorities cautioned that identifying a sole reason of autism - believed by scientists to be the consequence of a complicated interplay of genetic and environmental factors - would not be simple.

Autism is a form of lifelong neurodivergence and condition that impacts how persons experience and interact with the surroundings, and is identified using medical professional evaluations.

In his legal document, the attorney general - a Trump ally who is seeking federal office - claims Kenvue and Johnson & Johnson "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

The case aims to force the companies "destroy any marketing or advertising" that states Tylenol is reliable for women during pregnancy.

The court case parallels the complaints of a assembly of parents of young ones with autism and ADHD who filed suit against the makers of Tylenol in two years ago.

Judicial authorities dismissed the case, stating research from the plaintiffs' authorities was lacking definitive proof.